Publikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (11)

2024

  1. The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium

    Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 352-362

2023

  1. Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer

    Thrombosis Research, Vol. 232, pp. 133-137

2020

  1. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

    European Journal of Cancer, Vol. 141, pp. 193-198

  2. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

2019

  1. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

    Journal of Thoracic Oncology, Vol. 14, Núm. 7, pp. 1266-1276

  2. The Medical Oncology resident mentor: situation and workload

    Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 304-313

2018

  1. Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: Focusing on non-small cell lung cancer patients

    Journal of Thoracic Disease, Vol. 10, pp. S1516-S1533

2017

  1. Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey

    Annals of Oncology, Vol. 28, Núm. 7, pp. 1590-1596

2016

  1. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

    ESMO Open, Vol. 1, Núm. 6

2012

  1. Sorafenib in metastatic thyroid cancer

    Endocrine-Related Cancer, Vol. 19, Núm. 2, pp. 209-216

2011

  1. Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor,,in patients with advanced solid tumors

    Journal of Clinical Oncology, Vol. 29, Núm. 28, pp. 3783-3790